Relapsing hypocupraemic myelopathy requiring high-dose oral copper replacement

Area of Science:

• Neurology
• Nutritional Science
• Hematology

Background:

• Adult-onset copper deficiency is a recognized neurological syndrome.
• Oral copper replacement is the standard treatment.
• Relapsing hypocupraemic myelopathy presents a therapeutic challenge.

Observation:

• A patient presented with relapsing hypocupraemic myelopathy.
• The patient's condition initially responded to standard copper replacement therapy.
• Neurological symptoms recurred despite standard treatment.

Findings:

• Increased doses of oral copper replacement were required for sustained remission.
• Standard copper dosages may be insufficient for certain patients with this condition.
• This case highlights the variability in treatment response.

Implications:

• Treatment protocols for copper deficiency may need individualization.
• Further research into optimal dosing for hypocupraemic myelopathy is warranted.
• Understanding dose-response relationships is crucial for managing neurological complications of copper deficiency.